Oak Family Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,612
Closed -$224K 130
2024
Q4
$224K Sell
13,612
-94,350
-87% -$1.47M 0.08% 103
2024
Q3
$1.59M Sell
107,962
-1,133
-1% -$17.7K 0.49% 48
2024
Q2
$1.51M Buy
109,095
+1,454
+1% +$20.6K 0.52% 47
2024
Q1
$1.69M Buy
107,641
+7,663
+8% +$118K 0.65% 45
2023
Q4
$1.62M Buy
99,978
+3,241
+3% +$53K 0.68% 44
2023
Q3
$1.19M Sell
96,737
-1,541
-2% -$22.9K 0.56% 45
2023
Q2
$1.58M Sell
98,278
-1,168
-1% -$19.2K 0.75% 39
2023
Q1
$1.73M Sell
99,446
-1,748
-2% -$24.9K 0.85% 35
2022
Q4
$935K Buy
101,194
+1,894
+2% +$17.7K 0.5% 49
2022
Q3
$855K Buy
99,300
+10,696
+12% +$106K 0.46% 49
2022
Q2
$722K Buy
88,604
+5,915
+7% +$56.5K 0.36% 56
2022
Q1
$1M Buy
82,689
+24,569
+42% +$517K 0.39% 55
2021
Q4
$1.98M Buy
58,120
+555
+1% +$21.7K 0.74% 36
2021
Q3
$2.78M Buy
+57,565
New +$2.66M 1.01% 23

Other funds holding NEO

Oak Family Advisors's NEO Position: Q1 2025 in Review

Oak Family Advisors sold out of NeoGenomics (NEO) in Q1 2025, closing a stake of 13,612 shares — an estimated $224K sold.

Oak Family Advisors first reported a position in NEO in Q3 2021 and held it in 14 quarters. The position peaked at $2.78M in Q3 2021. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2025.

  • Oak Family Advisors reported no remaining NeoGenomics position as of Q1 2025 after selling out during the quarter.
  • Oak Family Advisors sold 13,612 NeoGenomics shares in Q1 2025, an estimated $224K.
  • Oak Family Advisors first reported a position in NeoGenomics in Q3 2021 and held it in 14 quarters.
  • Oak Family Advisors's NeoGenomics position peaked at $2.78M in Q3 2021.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2025.

Based on Oak Family Advisors's 13F filing for Q1 2025, filed 15 Apr 2025.